For 17% of GDP, we receive shorter lifespans and higher infant mortality. While most ire is directed at hospitals and pharmaceutical companies, middlemen or intermediaries – insurers, pharmacies, drug distributors, and pharmacy benefit managers (PBMs) – sit between patients and their care. |